The stock price of Cigna Group (NYSE: CI) has surged by 1.25 when compared to previous closing price of 342.41, but the company has seen a -2.90% decline in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-05-07 that Whether you’re a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is It Worth Investing in Cigna Group (NYSE: CI) Right Now?
Cigna Group (NYSE: CI) has a higher price-to-earnings ratio of 28.46x compared to its average ratio. CI has 36-month beta value of 0.55. Analysts have mixed views on the stock, with 7 analysts rating it as a “buy,” 6 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for CI is 278.91M, and currently, short sellers hold a 1.41% ratio of that float. The average trading volume of CI on May 08, 2024 was 1.49M shares.
CI’s Market Performance
The stock of Cigna Group (CI) has seen a -2.90% decrease in the past week, with a -3.15% drop in the past month, and a 5.84% gain in the past quarter. The volatility ratio for the week is 2.79%, and the volatility levels for the past 30 days are at 1.73% for CI. The simple moving average for the last 20 days is -1.33% for CI stock, with a simple moving average of 11.84% for the last 200 days.
Analysts’ Opinion of CI
Many brokerage firms have already submitted their reports for CI stocks, with Barclays repeating the rating for CI by listing it as a “Overweight.” The predicted price for CI in the upcoming period, according to Barclays is $393 based on the research report published on March 06, 2024 of the current year 2024.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see CI reach a price target of $354, previously predicting the price at $327. The rating they have provided for CI stocks is “Outperform” according to the report published on February 05th, 2024.
Cantor Fitzgerald gave a rating of “Overweight” to CI, setting the target price at $372 in the report published on February 05th of the current year.
CI Trading at -1.05% from the 50-Day Moving Average
After a stumble in the market that brought CI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.20% of loss for the given period.
Volatility was left at 1.73%, however, over the last 30 days, the volatility rate increased by 2.79%, as shares sank -3.02% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.28% upper at present.
During the last 5 trading sessions, CI fell by -2.90%, which changed the moving average for the period of 200-days by +18.02% in comparison to the 20-day moving average, which settled at $350.83. In addition, Cigna Group saw 15.78% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CI starting from Cordani David, who sale 31,209 shares at the price of $355.17 back on Mar 25 ’24. After this action, Cordani David now owns 348,054 shares of Cigna Group, valued at $11,084,357 using the latest closing price.
Cordani David, the Chairman & CEO of Cigna Group, sale 6,338 shares at $355.11 during a trade that took place back on Mar 22 ’24, which means that Cordani David is holding 348,054 shares at $2,250,682 based on the most recent closing price.
Stock Fundamentals for CI
Current profitability levels for the company are sitting at:
- 0.04 for the present operating margin
- 0.82 for the gross margin
The net margin for Cigna Group stands at 0.01. The total capital return value is set at 0.08. Equity return is now at value 8.45, with 2.49 for asset returns.
Based on Cigna Group (CI), the company’s capital structure generated 0.44 points at debt to capital in total, while cash flow to debt ratio is standing at 0.36. The debt to equity ratio resting at 0.79. The interest coverage ratio of the stock is 11.39.
Currently, EBITDA for the company is 5.16 billion with net debt to EBITDA at 7.49. When we switch over and look at the enterprise to sales, we see a ratio of 0.6. The receivables turnover for the company is 8.09for trailing twelve months and the total asset turnover is 1.38. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.83.
Conclusion
To put it simply, Cigna Group (CI) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
